Health Trials

Childhood Lymphoblastic Lymphoma

2

Review clinical trials related to Childhood Lymphoblastic Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration

This study evaluates the median duration of therapeutic serum asparaginase activity (SAA) levels after administration of calaspargase pegol (Cal-PEG) and the potential association between peak SAA levels and duration of therapeutic levels with toxicity in pediatric patients with acute lymphoblastic leukemia or lymphoma.

Participants needed: 20
Trial details
Age: Up to 21Biological sex: AllType: ObservationalSponsor: Mayo ClinicUpdated: Apr 2, 2026Locations: 1
Eligibility criteria

Acute lymphoblastic leukemia/lymphoma being treated by the pediatric hematology... [+1]

Age > 21 years [+2]

Read more
Status: Recruiting

Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study

This study evaluates the impact of calaspargase pegol (Cal-PEG) on the coagulation system in pediatric patients with acute lymphoblastic leukemia/lymphoma (ALL).

Participants needed: 15
Trial details
Age: 2-22Biological sex: AllType: ObservationalSponsor: Mayo ClinicUpdated: Feb 13, 2026Locations: 1
Eligibility criteria

Age 2-21.5 years [+3]

Pre-existing coagulation disorders [+5]

Read more